Documentary repository

Documents prepared as part of the project
Date	Document name
December 2023	Results of the II Consensus Conference
October 2023	Adaptation of the CMO Pharmaceutical Care Model to patients living with HIV infection
June 2023	Pharmaceutical guidelines for Atopic Dermatitis
April 2023	Pharmaceutical guidelines for Systemic Lupus Erythematosus
March 2023	Adaptation of the CMO pharmaceutical care model to patients with respiratory conditions
November 2022	Results of the MAPEX survey: 2016-2021 comparison of the situation of outpatient units. Advances and challenges
June 2022	aCadeMiO (Barbate, 3 June 2022)
June 2022	Quality medical and pharmaceutical care indicators in persons living with HIV
January 2022	Opinions and experiences of outpatients served by telepharmacy during the COVID-19 pandemic: the Enopex project
December 2021	Telepharmacy methodological support documents
August 2021	Development of the Q-PEX standard for certifying the quality of care provided to outpatients by pharmacy departments
November 2020	Pharmaceutical guidelines for rheumatoid arthritis
May 2020	Telepharmacy strategic framework
March 2020	Adaptation of the CMO pharmaceutical care model to patients with oncologic and hematologic neoplasms
October 2019	Pharmaceutical guidelines for psoriasis
October 2019	Pharmaceutical guidelines for spondyloarthropathies
May 2019	Stratification tool for patients with immuno-mediated conditions
May 2019	Stratification tool for hemato-oncologic patients
September 2018	Stratification and pharmaceutical care model for patients with hemato-oncologic conditions
September 2018	Stratification and pharmaceutical care model for patients with immuno-mediated inflammatory conditions
May 2017	Update on the adaptation of the Mapex project to the pharmaceutical industry
April 2017	Continuous improvement model for the integration of hospital pharmacists into multidisciplinary care teams
January 2017	Mapex work plan: initiatives for 2017
January 2017	Implementation of the CMO model in the outpatient units of hospital pharmacies
January 2016	MAPEX project phase 3 results: HIV and viral liver conditions
December 2015	MAPEX project phase 3 results: multiple sclerosis
December 2015	MAPEX project phase 3 results: immuno-mediated conditions
December 2015	MAPEX project phase 3 results: hemato-oncology
June 2015	MAPEX project phases 1 & 2: final report
June 2015	An analysis of trends in the hospital pharmacy setting

Documents prepared to publicize and showcase the MAPEX project
Date	Document name
December 2015	MAPEX 2015: summary of activities and results
June 2015	MAPEX Project Executive Summary
June 2015	MAPEX project public presentation

Nationwide results vs. regional results
Date	Document name
June 2016	Andalusia
June 2016	Aragon
June 2016	Asturias
June 2016	Balearic islands
June 2016	Canary islands
June 2016	Cantabria
June 2016	Castile-La Mancha
June 2016	Castile-Leon
June 2016	Catalonia
June 2016	Extremadura
June 2016	Galicia
June 2016	Madrid
June 2016	Murcia
June 2016	Navarre
June 2016	Basque Country
June 2016	Valencia

Opening address
Date	Document name
June 2015	José Luis Poveda. Member of the MAPEX Project Management Committee

Introduction to the MAPEX Project
Date	Document name
June 2015	Ramón Morillo. MAPEX Project Coordinator
June 2015	María Jesús Lamas. Member of the MAPEX Project Expert Committee

The MAPEX project as seen by the guest speakers at the Consensus Conference
Date	Document name
June 2015	Manuel González. Managing Director, Virgen del Rocío-Virgen Macarena University hospitals
June 2015	María Sanjurjo. Head of the Pharmacy Department, Gregorio Marañón University Hospital
June 2015	José Luis Calleja, Department of Gastroenterology and Hepatology, Puerta de Hierro University Hospital, Madrid
June 2015	Jorge Garrido. Positive support manager

Closing lecture
Date	Document name
June 2015	Miguel Ángel Calleja. Member of the MAPEX Project Management Committee

Documentary repository

MAPEX Project results

Presentations delivered at the MAPEX consensus conference